CRA analyzed market definition in antitrust litigation concerning a product in the non-opioid pain category. In defining the relevant antitrust market, our work accounted for indicators of competition among branded pharmaceutical products, including market positioning, factors driving physician choice, development of new approved indications, and competition for formulary listing.
New research analyzes the impact of hazardous waste management on US economic growth
Improper management of hazardous waste can contaminate soil and drinking water, release toxic air pollutants, and create serious health risks for exposed...